Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines.

Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4608692?pdf=render

Similar Items

Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.
by: Christopher B Sullivan, et al.
Published: (2015-01-01)

Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
by: Paola Stefanelli, et al.
Published: (2017-05-01)

Serogroup C meningococci in Italy in the era of conjugate menC vaccination
by: Neri Arianna, et al.
Published: (2009-08-01)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
by: Domenico Martinelli, et al.
Published: (2015-01-01)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
by: Márcia de Cantuária Tauil, et al.
Published: (2014-07-01)

Clonal Expansion of Sequence Type (ST-)5 and Emergence of ST-7 in Serogroup A Meningococci, Africa
by: Pierre Nicolas, et al.
Published: (2001-10-01)

Meningococcal disease serogroup C
by: Cuevas IE, et al.
Published: (2012-03-01)

Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
by: C.A.C. Gioia, et al.

Cluster of Serogroup W135 Meningococci, Southeastern Florida, 2008–2009
by: Timothy J. Doyle, et al.
Published: (2010-01-01)

Serogroup C invasive meningococcal disease in the post-vaccine era and vaccine failures
by: Neus Rius, et al.
Published: (2020-12-01)

Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.
by: Désirée E Bennett, et al.
Published: (2020-01-01)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
by: Maiden, Martin C.J, et al.
Published: (2008)

Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.
by: Richarda M de Voer, et al.
Published: (2010-01-01)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
by: Mariëtte B van Ravenhorst, et al.
Published: (2018-01-01)

Meningococcal disease in England and Wales : analysing the impact of serogroup C conjugate vaccination
by: Trotter, Caroline Louise
Published: (2004)

Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger
by: Halima Boubacar Maïnassara, et al.
Published: (2015-08-01)

Distribution of Serogroups of Neisseria meningitidis and Antigenic Characterization of Serogroup Y Meningococci in Canada, January 1, 1999 to June 30, 2001
by: Raymond SW Tsang, et al.
Published: (2002-01-01)

The molecular characterisation of Neisseria meningitidis in Scotland before, during and after the initial introduction of the meningococcal serogroup C conjugate (MenC) vaccines
by: Diggle, Mathew A.
Published: (2004)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01)

Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
by: Dr Joan L Robinson
Published: (2015-01-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)

Modelling the impact of vaccination targeted against serogroup B meningococcal disease
by: Christensen, Hannah
Published: (2011)

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
by: Nicole Le Saux, et al.
Published: (2009-01-01)

Meningococcal serogroup A and tetanus immunity two years after MenAfriVac™ introduction in Mali
by: N.E. Basta, et al.
Published: (2014-04-01)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
by: Emil Kupek, et al.

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
by: Kupek Emil, et al.
Published: (2001-01-01)

Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection
by: Williams, Jeannette N., et al.
Published: (2003)

Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America
by: Andrew J. Pollard, et al.
Published: (2004-10-01)

Serogroup Y Meningococcal Disease, Colombia
by: Clara Inés Agudelo, et al.
Published: (2008-06-01)

Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.
by: Wesley Mattheus, et al.
Published: (2015-01-01)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
by: Marco Aurelio Palazzi Sáfadi, et al.
Published: (2014-05-01)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
by: Hedari CP, et al.
Published: (2014-04-01)

Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci
by: Mingliang Chen, et al.
Published: (2021-04-01)

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
by: Paul Balmer, et al.
Published: (2018-06-01)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
by: Kaaijk Patricia, et al.
Published: (2012-02-01)

Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.
by: Hiltsje Hepkema, et al.
Published: (2013-01-01)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
by: Luiz Silva JD, et al.
Published: (2010-06-01)

Toward an Improved Meningococcal Serogroup B Assay
by: Jan Poolman
Published: (2018-05-01)

Serogroup X in Meningococcal Disease, Western Kenya
by: Sadiki Materu, et al.
Published: (2007-06-01)